
Jagsonpal Pharmaceuticals Investor Relations Material
Latest events

Q2 24/25
Jagsonpal Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Jagsonpal Pharmaceuticals Limited
Access all reports
Jagsonpal Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of branded generic formulations. The company offers a range of dosage forms including tablets, capsules, syrups, and injectables across therapeutic segments such as gynecology, orthopedics, dermatology, and general medicine. It serves domestic and international markets through an established distribution network and field force. The company is headquartered in New Delhi, India, and its shares are listed on the BSE.
Key slides for Jagsonpal Pharmaceuticals Limited


Q3 24/25
Jagsonpal Pharmaceuticals Limited


Q3 24/25
Jagsonpal Pharmaceuticals Limited
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
JAGSNPHARM
Country
🇮🇳 India